Tangle of data puts policymaking on pause. Royalty Pharma urges U.S. court to let Elan bid proceed. Report: NSA contract worker is surveillance source
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark
Castle wines Reader VIDEO: Futures Drift Higher Ahead Of Data
U.S. stock index futures rose on Thursday, following three days of declines on the S&P 500, as traders digested the Federal Reserve's latest assessment of the economy ahead of key inflation an... VIDEO: Japan Holds Rates Steady
The Bank of Japan maintained its ultra-loose monetary policy on Thursday and reiterated that the economy was recovering moderately, in a nod to signs of an increase in exports that is key to s... VIDEO: JPMorgan $13 Billion Mortgage Deal Expected Tuesday
JPMorgan Chase & Co. is expected on Tuesday to sign a $13 billion deal with the U.S. government to settle claims that the bank misrepresented the quality of the mortgages it sold to investors ... VIDEO: Futures Flat After 8-week Run-up; Data On Tap
U.S. stock index futures were little changed on Monday in the wake of eight straight weeks of gains after mixed data on China and the euro zone and ahead of U.S. economic reports which could p... VIDEO: Stock Futures Flat As Market Takes Breather After Rally
U.S. stock index futures were little changed on Monday as the market was set to take a breather after the Dow and the S&P 500 rose for the fifth consecutive week. On Friday, the benchmark S&P ... by Amazon Auto Links
This entry was posted in
gold and tagged business news, Central bank, Companies listed on the New York Stock Exchange, Crime prevention, Elan Corp., Eln, Keynesian economics, lan, Late-2000s recession, Law enforcement, london, Macroeconomic policy, Mass surveillance, Monetary policy, Natalizumab, National Security Agency, New York, Privacy, Public finance, royalties, stimulus, The Guardian, U.S. court, U.S. government, United States. Bookmark the permalink.